Linn S.
- Country
- Norway
- Department
- Dept. of Neurology
Research Overview
- Comparative Efficacy and Safety of Autologous Hematopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine, or Ocrelizumab in Relapsing-Remitting Multiple Sclerosis
- Investigation of Intrathecal Autologous Mesenchymal Stromal Cells for Neuroregeneration in Progressive Multiple Sclerosis: A Controlled Clinical Trial
- A Multicenter Non-Inferiority Trial Comparing Rituximab and Ocrelizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis Aged 18-60 Years
Data & Insights
Has run more than one trial at 9 of 118 partner sites.
Specializations
Multiple Sclerosis Research
This investigator demonstrates significant expertise in multiple sclerosis treatment approaches, with particular focus on both relapsing-remitting and progressive forms of the disease.
- Novel therapeutic comparisons in RRMS
- Stem cell therapy investigations
- Progressive MS interventions
The research encompasses innovative treatment modalities including cell-based therapies and targeted molecular approaches.
Migraine Studies
The investigator shows dedicated interest in migraine management, exploring both episodic and chronic manifestations of the condition.
- Preventative therapy evaluation
- Chronic migraine interventions
- Novel therapeutic applications
Research focuses on preventative treatment approaches for different migraine presentations.
Neurological Therapeutics
The investigator specializes in advanced neurological treatments, including cellular and molecular therapeutic approaches.
- Immunomodulatory therapies
- Neuroregenerative treatments
- Progressive neurological conditions
Expertise extends to innovative treatment modalities across various neurological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.